Arch Biopartners Inc. (ARCH), a biopharmaceutical company, Friday announced that it has appointed Patrick Vink as Chairman of the company, effective January 15.
He succeeds Claude Allary who has retired from the company.
Vink previously served as Executive Vice President and Chief Operating Officer of Cubist Pharmaceuticals, Inc. and prior to that he was he was Senior Vice President, Global Head of Hospital Business and Biologics for Mylan Inc. now Viatris Inc.
On Thursday, ARCH shares closed at C$1.37 on the TSXV.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.